Cancer drugs are designed to shut tumors down. But sometimes, in the very act of attacking a tumor, treatment can also help a small fraction of cancer cells become harder to kill. A new study from ...

SKIMS data recorded over 50,000 cancer cases between 2014 and 2024. Nun chai, smoked meat, pesticide-bombarded vegetables, ...

A new research paper was published in Volume 17 of Oncotarget on March 31, 2026, titled “Epigenetic dysregulation and ...

A new study helps explain why a promising class of cancer drugs has often failed to meet expectations in clinical trials.

Charles W.M. Roberts, MD, PhD, executive vice president and Comprehensive Cancer Center director at St. Jude Children's ...

Andrew Feinberg, Bloomberg Distinguished Professor of Epigenetics at Johns Hopkins University Schools of Medicine, Engineering and Public Health, has been awarded the 2026 AACR-G.H.A. Clowes Award for ...

A new study indicates scientists may be able to tell if a baby was breastfed by a blood test.

Broadcast Retirement Network's Jeffrey Snyder discusses a single test to detect cancer and other diseases with UCLA's Jasmine ...

WHAT: Researchers from the Johns Hopkins Kimmel Cancer Center will present new research findings and receive honors and ...

Kazia Therapeutics is paying $1.4 million upfront to secure a platform for generating epigenetic drugs from an Australian research institute. Brisbane-based QIMR Berghofer develop ...

Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new ...